Pathologic features of ulcerative colitis in patients with primary sclerosing cholangitis: A case-control study

American Journal of Surgical Pathology

Volumn 33, Issue 6, 2009, Pages 854-862

  Joo, Mee ^e   Abreu E Lima, Paula ^a   Farraye, Francis ^c   Smith, Timothy ^d   Swaroop, Prabhakar ^d   Gardner, Laura ^d   Lauwers, Gregory Y ^b   Odze, Robert Daniel ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c BOSTON MEDICAL CENTER   (United States)

^d SAINT LOUIS UNIVERSITY HOSPITAL   (United States)

^e Inje University   (South Korea)

Author keywords

Crohn disease; Dysplasia; Ileitis; Inflammatory bowel disease; Pouchitis; Primary sclerosing cholangitis; Ulcerative colitis

Indexed keywords

ADULT; ARTICLE; ASCENDING COLON; CECUM; CLINICAL ARTICLE; CLINICAL FEATURE; COLON BIOPSY; COLON MUCOSA; CONTROLLED STUDY; DESCENDING COLON; DISEASE ACTIVITY; DYSPLASIA; ENDOSCOPY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; ILEITIS; INCIDENCE; MALE; PREVALENCE; PRIMARY SCLEROSING CHOLANGITIS; RECTUM; TRANSVERSE COLON; ULCERATIVE COLITIS; ADOLESCENT; CASE CONTROL STUDY; CHILD; MIDDLE AGED; ONSET AGE; PATHOLOGY; PRESCHOOL CHILD; SCLEROSING CHOLANGITIS;

ADOLESCENT; ADULT; AGE OF ONSET; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CHOLANGITIS, SCLEROSING; COLITIS, ULCERATIVE; FEMALE; HUMANS; MALE; MIDDLE AGED;

EID: 67549107974     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e318196d018     Document Type: Article

References (34)

1. Aadland E, Schrumpf E, Fausa O, et al. Primary sclerosing cholangitis: a long-term follow-up study. Scand J Gastroenterol. 1987;22:655-664.
2. Bergquist A, Ekbom A, Olsson R, et al. Hepatic and extrahepatic malignancies in primary sclerosing cholangitis. J Hepatol. 2002;36: 321-327.
3. Bernstein CN, Shanahan F, Anton PA, et al. Patchiness of mucosal inflammation in treated ulcerative colitis: a prospective study. Gastrointest Endosc. 1995;42:232-237.
4. Bernstein CN, Blanchard JF, Rawsthorne P, et al. The prevalence of extraintestinal diseases in inflammatory bowel disease: a population-based study. Am J Gastroenterol. 2001;96:1116-1122.
5. Broomé U, Bergquist A. Primary sclerosing cholangitis, inflammatory bowel disease, and colon cancer. Semin Liver Dis. 2006;26: 31-40.
6. Ekbom A, Helmick C, Zack M, et al. Ulcerative colitis and colorectal cancer. A population based study. N Engl J Med. 1990; 323:1228-1233.
7. Faubion WA, Loftus EV, Sandborn WJ, et al. Pediatric "PSC-IBD": a descriptive report of associated inflammatory bowel disease among pediatric patients with PSC. J Pediatr Gastroenterol Nutr. 2001;33:296-300.
8. Gurbuz AK, Giardiello FM, Bayless TM. Colorectal neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis. Dis Colon Rectum. 1995;38:37-41.
9. Haskell H, Andrews CW, Reddy S, et al. Pathologic features and clinical significance of "backwash" ileitis in ulcerative colitis. Am J Surg Pathol. 2005;29:1472-1481.
10. Heuschen U, Hinz U, Allemeyer E, et al. Backwash ileitis is strongly associated with colorectal carcinoma in ulcerative colitis. Gastroenterology. 2001;120:841-847.
11. Karlsen TH, Boberg KM, Vatn M, et al. Different HLA class II associations in ulcerative colitis patients with and without primary sclerosing cholangitis. Genes Immun. 2007;8:275-278.
12. Kleer CG, Appelman HD. Ulcerative colitis: patterns of involvement in colorectal biopsies and changes with time. Am J Surg Pathol. 1998;22:983-989.
13. Knobler H, Ligumsky M, Okon E, et al. Pouch ileitis: recurrence of the inflammatory bowel disease in the ileal reservoir. Am J Gastroenterol. 1986;81:199-201.
14. Loftus EV, Harewood GC, Loftus CG, et al. PSC-IBD: a unique form of inflammatory bowel disease associated with primary sclerosing cholangitis. Gut. 2005;54:91-96.
15. Lundqvist K, Broome U. Differences in colonic disease activity in patients with ulcerative colitis with and without primary sclerosing cholangitis: a case control study. Dis Colon Rectum. 1997;40: 451-456.
16. Moayyeri A, Daryani N, Bahrami H. Clinical course of ulcerative colitis in patients with and without primary sclerosing cholangitis. J Gastroenterol Hepatol. 2005;20:366-370.
17. Naggengast F, Grubben M, van Munster I. Role of bile acids in colorectal carcinogenesis. Eur J Cancer. 1995;31:1067-1070.
18. Nuako KW, Ahlquist DA, Sandborn WJ, et al. Primary scleros-ing cholangitis and colorectal carcinoma in patients with chronic ulcerative colitis: as case-control study. Cancer. 1998;82: 822-826.
19. Odze RD, Antonioli D, Peppercorn M, et al. Effect of topical 5-aminosalicylic acid (5-ASA) therapy on rectal mucosal biopsy morphology in chronic ulcerative colitis. Am J Surg Pathol. 1993; 27:864-875.
20. Olsson R, Danielsson A, Jarnerot G, et al. Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis. Gastroenterology. 1991;100:1319-1323.
21. Pardi D, Lofus E Jr, Kremers W, et al. Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis. Gastroenterology. 2003;124: 889-893.
22. Penna C, Dozois R, Tremaine W, et al. Pouchitis after ileal pouch-anal anastomosis for ulcerative colitis occurs with increased frequency in patients with associated primary sclerosing cholangitis. Gut. 1996;38:234-239.
23. Perdigoto R, Wiesner RH, LaRusso NF, et al. Inflammatory bowel disease associated with primary sclerosing cholangitis: incidence, severity and relationship to liver disease. Gastroenterology. 1991; 100:A238.
24. Rutter M, Saunders B, Wilkinson K, et al. Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology. 2004;126:451-459.
25. Sandborn WJ, Lindor KD, Wiesner RH, et al. Ulcerative colitis (UC) disease activity after treatment of associated primary sclerosin cholangitis (PSC) with ursodeoxycholic acid (URSO) or placebo. Gastroenterology. 1992;102:690A.
26. Schrumpf E, Elgio K, Fausa O, et al. Sclerosing cholangitis in ulcerative colitis. Scand J Gastroenterol. 1980;15:689-697.
27. Shen B, Achkar JP, Lashner BA, et al. Endoscopic and histologic evaluation together with symptom assessment are required to diagnose pouchitis. Gastroenterology. 2001;121:261-267.
28. Shepherd HA, Shelby WS, Chapman RWG, et al. Ulcerative colitis with persistent liver dysfunction. Quart J Med. 1983;52: 503-513.
29. Shetty K, Rybicki L, Brzezinski A, et al. The risk for cancer or dysplasia in ulcerative colitis patients with primary sclerosing cholangitis. Am J Gastroenterol. 1999;94:1643-1649.
30. Smith M, Loe S. Sclerosing cholangitis: review of recent case reports and associated diseases and four new cases. Am J Surg. 1965;110: 239-246.
31. Soetikno R, Lin O, Heidenreich P. Increased risk of colorectal neo-plasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis. Gastrointest Endosc. 2002;56:48-54.
32. Takikawa H, Manabe T. Primary sclerosing cholangitis in Japan - analysis of 192 cases. J Gastroenterol. 1997;32:134-137.
33. Tung B, Emond M, Haggitt R, et al. Ursodiol use is associated with lower prevalence of colonic neoplasia in patients with ulcerative colitis and primary sclerosing cholangitis. Ann Intern Med. 2001;134: 89-95.
34. Yantiss R, Sapp H, Farraye F. Histologic predictors of pouchitis in patients with chronic ulcerative colitis. Am J Surg Pathol. 2004;28: 999-1006.